|
1
|
Adams HJ, Kwee TC. A 73% Price Reduction Does Not Indisputably Justify Routine Application of Brentuximab Vedotin as First-Line Treatment of Hodgkin Lymphoma. J Clin Oncol 2019; 37:852-853. [DOI: 10.1200/jco.18.01830] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023] Open
Affiliation(s)
- Hugo J.A. Adams
- Hugo J.A. Adams, MD, PhD, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; and Thomas C. Kwee, MD, PhD, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
| | - Thomas C. Kwee
- Hugo J.A. Adams, MD, PhD, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; and Thomas C. Kwee, MD, PhD, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
| |
Collapse
|
|
2
|
Benefit of brentuximab over bleomycin in first-line treatment of advanced-stage Hodgkin lymphoma has not been proven. Blood 2018; 132:339-340. [PMID: 29858234 DOI: 10.1182/blood-2018-04-845438] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
|
|
3
|
Adams HJA, Kwee TC. Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma. Br J Haematol 2017; 184:290-292. [PMID: 29265351 DOI: 10.1111/bjh.15071] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Hugo J A Adams
- Department of Radiology and Nuclear Imaging, Deventer Hospital, Deventer, the Netherlands
| | - Thomas C Kwee
- Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
| |
Collapse
|
|
4
|
Kaste SC, Metzger M, Shulkin BL. Reply: The Need for Prudence When Using 18F-FDG PET as a Reference Standard for Lymphoma Detection. J Nucl Med 2017; 58:1355. [PMID: 28450559 DOI: 10.2967/jnumed.117.190652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Sue C Kaste
- St. Jude Children's Research Hospital 262 Danny Thomas Place, Mail Stop 220 Memphis, Tennessee 38105 E-mail:
| | | | | |
Collapse
|